Immunis Inc.
Organization Description
Immunis is a private biotechnology company researching and developing secretome products to combat age-related immune deficits. Their secretome product, Immuna delivers immune modulators to address problems with the immune system and to encourage healthy function. Immunis is currently testing the effects of Immuna in a Phase 1/2a clinical trial for muscle atrophy (sarcopenia).
Team
